Periscope Capital’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Periscope Capital’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-383,533	Closed	-$30.6K	–	788
2023 Q1	$30.6K	Hold	383,533	–	–	﹤0.01%	607
2022 Q4	$58.9K	Buy	383,533 +254,441	+197%	+$29.3K	﹤0.01%	546
2022 Q3	$22K	Buy	129,092 +9,192	+8%	+$1.99K	﹤0.01%	858
2022 Q2	$18K	Hold	119,900	–	–	﹤0.01%	983
2022 Q1	$44K	Hold	119,900	–	–	﹤0.01%	985
2021 Q4	$115K	Buy	+119,900	New	+$125K	﹤0.01%	805

Periscope Capital's ORIAW Position: Q2 2023 in Review

Periscope Capital sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 383,533 shares — an estimated $30.6K sold.

Periscope Capital first reported a position in ORIAW in Q4 2021 and held it in 6 quarters. The position peaked at $115K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Periscope Capital reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Periscope Capital sold 383,533 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $30.6K.
Periscope Capital first reported a position in Orion Biotech Opportunities Corp. Warrant in Q4 2021 and held it in 6 quarters.
Periscope Capital's Orion Biotech Opportunities Corp. Warrant position peaked at $115K in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Periscope Capital's 13F filing for Q2 2023, filed 14 Aug 2023.